⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant

Official Title: A Randomized Multicenter Study Comparing Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma Who Have Relapsed After Therapy With CHOP-R or an Equivalent Regimen and Are Ineligible for Stem Cell Transplant

Study ID: NCT01321541

Study Description

Brief Summary: The purpose of this study is to evaluate the efficacy of Pixantrone + Rituximab compared to Gemcitabine + Rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), or follicular grade 3 lymphoma.

Detailed Description: Eligible patients will be randomized to treatment with pixantrone plus rituximab or gemcitabine plus rituximab in up to six 28-day cycles. At the time patients experience progressive disease during study treatment, early follow- up, or intermediate follow-up, they enter the survival follow up period. Patients who complete study treatment or discontinue study treatment for any other reason will participate in the follow-up periods. Early Follow-Up: After treatment completion or discontinuation, patient will enter a 24-week follow-up period. Intermediate Follow-Up: After completing the 24-week early follow-up period, patient will enter an additional 72-week follow-up period. Survival Follow-Up: All patients will be monitored for survival.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Arizona Clinical Research Center, Tucson, Arizona, United States

Arizona Oncology Associates, Tucson, Arizona, United States

Highlands Oncology Group, Bentonville, Arkansas, United States

Highlands Oncology Group, Fayetteville, Arkansas, United States

Rocky Mountain Cancer Centers, Aurora, Colorado, United States

Rocky Mountain Cancer Centers, Boulder, Colorado, United States

Rocky Mountain Cancer Centers, Denver, Colorado, United States

George Washington University Department of Medicine, Washington, District of Columbia, United States

Integrated Community Oncology Network-St. Vincent's, Jacksonville, Florida, United States

Integrated Community Oncology Network-Southside, Jacksonville, Florida, United States

Integrated Community Oncology Network, Orange Park, Florida, United States

Carle Physician Group, Danville, Illinois, United States

Cancer Care Specialists of Central Illinois, Decatur, Illinois, United States

Crossroads Cancer Center, Effingham, Illinois, United States

Carle Foundation Physician Services, Mattoon, Illinois, United States

Carle Cancer Center, Urbana, Illinois, United States

Cancer Center of Kansas, Wichita, Kansas, United States

Cancer Center of Kansas, Wichita, Kansas, United States

Baptist Hospital East, Louisville, Kentucky, United States

Harry and Jeanette Weinberg Cancer Institute at Franklin Square, Baltimore, Maryland, United States

Center for Cancer and Blood Disorders, PC, Bethesda, Maryland, United States

Cancer & Hematology Center of Western Michigan, Grand Rapids, Michigan, United States

Metro Minnesota CCOP-Unity Hospital, Fridley, Minnesota, United States

Metro Minnesota CCOP-St. Johns, Maplewood, Minnesota, United States

Metro Minnesota Community Clinical Oncology Program, Saint Louis Park, Minnesota, United States

Metro Minnesota Community Clinical Oncology Program, Saint Louis Park, Minnesota, United States

Metro Minnesota CCOP-Regions Hospital, Saint Paul, Minnesota, United States

Missouri Cancer Associates, Columbia, Missouri, United States

Nebraska Hematology-Oncology, PC, Lincoln, Nebraska, United States

Hematology-Oncology Associates of Northern New Jersey, Morristown, New Jersey, United States

North Shore Hematology/Oncology Associates, East Setauket, New York, United States

Gabrail Cancer Center, Canton, Ohio, United States

Gabrail Cancer Center, Dover, Ohio, United States

Toledo Clinical Cancer Center, Toledo, Ohio, United States

Mercy Cancer Center at St. Anne's, Toledo, Ohio, United States

Toledo Clinic Cancer Center-Toledo, Toledo, Ohio, United States

Northwest Cancer Specialists, PC, Portland, Oregon, United States

Northwest Cancer Specialists, PC, Portland, Oregon, United States

Northwest Cancer Specialists, PC, Tualatin, Oregon, United States

Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

Upstate Oncology Associates, Greenville, South Carolina, United States

South Carolina Cancer Specialists, Hardeeville, South Carolina, United States

South Carolina Cancer Specialists, Hilton Head Island, South Carolina, United States

Joe Arrington Cancer Research and Treatment Center, Lubbock, Texas, United States

Cancer Care Centers of South Texas-HOAST, New Braunfels, Texas, United States

Cancer Care Centers of South Texas-HOAST, San Antonio, Texas, United States

Blue Ridge Cancer Care, Roanoke, Virginia, United States

Northwest Cancer Specialists, PC, Vancouver, Washington, United States

Northwest Cancer Specialists, PC, Vancouver, Washington, United States

Saint Vincent Hospital Green Bay Oncology, Green Bay, Wisconsin, United States

Green Bay Oncology-St. Mary's Hospital MC, Green Bay, Wisconsin, United States

Medical University Innsbruck, Department of Internal Medicine V (Hematology and Oncology), Innsbruck, , Austria

Hospital Elisabethinen Linz, Internal Department 1 - Hemato-Oncology, Linz, , Austria

Hanusch Hospital, Department of Internal Medicine III, Vienna, , Austria

Saint Luc University Hospital, Department of Hematology, Brussels, , Belgium

General Hospital Delta, Hematology Department, Roeselare, , Belgium

General Hospital Turnhout, Hematology Department, Turnhout, , Belgium

UMHAT "Sveti Georgi", Plovdiv, Clinical Hematology Clinic, Plovdiv, , Bulgaria

UMHAT "Sveti Georgi", Plovdiv, Department of Medical Oncology, Plovdiv, , Bulgaria

MHAT "Tokuda Hospital Sofia", Hematology Clinic, Sofia, , Bulgaria

University Multiprofile Hospital for Active Treatment "Sveti Ivan Rilski", Department of Clinical Hematology, Sofia, , Bulgaria

Specialized Hospital For Active Treatment Of Hematological Diseases, Sofia, Clinical Hematology Clinic, Sofia, , Bulgaria

MHAT Hristo Botev, Vratsa, First Department of Internal Medicine, Vratsa, , Bulgaria

University Hospital Brno, Clinic of Internal Medicine - Hematology and Oncology, Brno, , Czechia

University Hospital Hradec Kralove, 4th Department of Internal Medicne, Clinical Hematology, Hradec Kralove, , Czechia

University Hospital Ostrava, Institute of Clinical Hematology, Ostrava, , Czechia

University Hospital Kralovske Vinohrady, Department of Clinical Hematology, Prague, , Czechia

General University Hospital in Prague, 1st Department of Internal Medicine - Department of Hematology, Prague, , Czechia

Aalborg University Hospital, Department of Hematology, Aalborg, , Denmark

Service d'hématologie clinique, Avenue Laennec Salouel, Amiens, Cedex 1, , France

Centre hopitalier de la cote basque, Bayonne, , France

Centre hospitalier de Beziers, Beziers, , France

Polyclinique de Bordeaux nord Acquitaine, Bordeaux, , France

Centre hospitalier du Mans, Le Mans Cedex 03, , France

Centre hospitalier Lyon Sud, Pierre Benite Cedex, , France

Saint Quentin Hospital Center, Department of Oncology-Hematology, Saint-Quentin, , France

Hautepierre Hospital, Department of Hematology and Oncology, Strasbourg Cedex, , France

Gemeinschaftspraxis Drs. Klausmann, Aschaffenburg, , Germany

Klinikum Chemnitz gGmbH, Chemnitz, , Germany

Klinik für Innere Medizin III, Frankfurt (a.M.), , Germany

Universitaetsklinikum Halle, Halle (Saale), , Germany

St. Marien Hospital Hamm, Hamm, , Germany

Universitätsklinik Köln, Köln, , Germany

Klinikum Nürnberg Nord, Nürnberg, , Germany

Klinikum Mutterhaus der Borromäerinnen, Trier, , Germany

St. Istvan and St. Laszlo Hospital of Budapest, Budapest, , Hungary

University of Debrecen, Debrecen, , Hungary

Moritz Kaposi General Hospital, Kaposvár, , Hungary

University Hospital "Ospedali Riuniti Umberto I - G.M. Lancisi - G. Salesi", Ancona, , Italy

Bologna University Hospital Authority St. Orsola-Malpighi Polyclinic, Bologna, , Italy

Scientific Institute of Romagna for the Study and Treatment of Cancer (I.R.S.T.) S.R.L., Meldola, , Italy

"Ospedali Riuniti Villa Sofia-Cervello" Hospital, Palermo, , Italy

Romagna Local Health Authority (AUSL Romagna) - "Santa Maria delle Croci", Ravenna, , Italy

Romagna Local Health Authority (AUSL Romagna) - "Infermi" Hospital, Rimini, , Italy

Siena University Hospital Authority Santa Maria alle Scotte Polyclinic, Siena, , Italy

Santa Maria Hospital, Terni, , Italy

A.O.U. Città della Salute e della Scienza di Torino, Torino, , Italy

Independent Public Healthcare Facility Municipal Hospital Group, Chorzów, , Poland

Marine Hospital of Polish Red Cross, Department of Chemotheraphy, Gdynia, , Poland

Silesia Medical University, Department of Hematology and Bone Marrow Transplantation, Katowice, , Poland

Malopolskie Medical Center S.C. , Department of Hematology, Krakow, , Poland

Nicolaus Copernicus Memorial Provincial Specialist Hospital in Lodz, Lodz, , Poland

Oncology Center of Lublin Land, Department of Clinical Oncology, Lublin, , Poland

Institute of Hematology and Transfusion Medicine, Clinic of Hematology, Warsaw, , Poland

Wroclaw Medical University, Department and Clinic of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw, , Poland

Rapid Diagnosis Polyclinic SA, Brasov, , Romania

Fundeni Clinical Institute Center for Hematology and Bone Marrow Transplantation, Bucharest, , Romania

Bucharest University Emergency Hospital, Hematology Clinic, Bucharest, , Romania

State Budget Healthcare Institution of Sverdlovsk region: Sverdlovsk Regional Clinical Hospital #1, Ekaterinburg, , Russian Federation

Federal State Public Institution: Main Military Clinical Hospital n.a. N.N. Burdenko of the Russian Ministry of Defense, Moscow, , Russian Federation

Moscow State Budget Medical Institution: City Clinical Hospital n.a. S.P.Botkin, Moscow, , Russian Federation

State Medical Institution: Republican Hospital named after V.A. Baranov, Petrozavodsk, , Russian Federation

St. Petersburg Clinical Research and Practical Center for Specialized Types of Medical Care, St. Petersburg, , Russian Federation

State Healthcare Institution: Republican Clinical Oncology Center, Ufa, , Russian Federation

University Hospital with Outpatient Clinic F.D. Roosevelt Banska Bystrica, Department of Hematology, Banska Bystrica, , Slovakia

National Cancer Institute, Department of Hematology and Transfusiology, Bratislava, , Slovakia

University Hospital Martin, Department of Hematology and Transfusiology, Martin, , Slovakia

J. A. Reiman University Hospital with Polyclinic in Presov, Presov, , Slovakia

A Coruña University Hospital, A Coruña, , Spain

Hospital Universitario Vall Hebrón, Barcelona, , Spain

Hospital Iniversitario Puerta del Mar, Cadiz, , Spain

Institut Català de Oncologia (ICO), Hospital Dr Trueta, Girona, , Spain

Hospital Iniversitario La Paz, Madrid, , Spain

Hospital Universitario Araba, Vitoria, , Spain

Cherkasy Regional Oncology Center, Regional Treatment and Diagnostic Hematology Center, Cherkasy, , Ukraine

Kharkiv Regional Clinical Oncology Center, Kharkiv, , Ukraine

National Institute of Cancer, Kyiv, , Ukraine

State Institution: Institute of Blood Pathology and Transfusion Medicine, Lviv, , Ukraine

Beatson West of Scotland Cancer Center, Glasgow, , United Kingdom

St. George's Healthcare NHS Trust, London, , United Kingdom

Christie Hospital, Department of Medical Oncology, Manchester, , United Kingdom

Contact Details

Name: Simran B Singh, MS, GWCP

Affiliation: Sr. Director, Clinical Operations

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: